Back
AnGes 10K Form
Sell
28
AMGXF
AnGes
Last Price:
0.54
Seasonality Move:
-22.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AMGXF News And Ratings
See the #1 stock for the next 7 days that we like better than AMGXF
AMGXF Financial Statistics
Sales & Book Value
| Annual Sales: | $1.09M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.67 |
| Price / Book: | 0.82 |
Profitability
| EPS (TTM): | -0.20040 |
|---|---|
| Net Income (TTM): | $-40.7M |
| Gross Margin: | $138.59K |
| Return on Equity: | -22.74% |
| Return on Assets: | -19.39% |
AnGes Earnings Forecast
Key AnGes Financial Ratios
- The Gross Profit Margin over the past 16 years for AMGXF is 12.71%.
- The Selling, General & Administrative Expenses for AMGXF have been equal to 3,800.36% of Gross Profit Margin.
- The Research & Development expenses have been 4,034.98% of Revenue.
- The Interest Expense is -0.29% of Operating Income.
- The Net Earning history of AMGXF is -4,861.63% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 9 years.
AnGes Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AMGXF |
| Website: | anges.co.jp |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.86 |
| Quick Ratio: | 1.1 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |